The Growth Hormone Pathway
Detailed examination of how peptides interact with the growth hormone axis, including the hypothalamus-pituitary connection and downstream effects.
The GH Axis Overview
Every growth hormone (GH) peptide acts somewhere on one chain; our overview of how peptides work covers other pathways.
Hypothalamic Control
The hypothalamus regulates GH through two hormones:
- GHRH (growth hormone releasing hormone): stimulates GH release
- Somatostatin: inhibits GH release
- Ghrelin, from the stomach, adds a third input
- The balance creates pulsatile release
Pituitary Response
- Somatotroph cells produce and store GH
- GHRH triggers release; somatostatin blocks it
- In a 1988 study of six men, GH came in about 6 daily pulses when fed, 10 after a 5-day fast
Peripheral Actions
- GH acts on many tissues directly
- The liver produces IGF-1 in response
- Negative feedback loops exist
Peptide Interaction Points
GHRH Analogs (CJC-1295, Sermorelin)
- Mimic natural GHRH at its pituitary receptor
- Sermorelin, formerly FDA-approved as Geref, hasn't been marketed under that name in the US since 2008. In 11 older men, 6 weeks of nightly use raised overnight GH but not IGF-1
- CJC-1295 with DAC lasts about a week in the blood. In 2006 single-dose trials, GH stayed raised for 6+ days and IGF-1 for 9-11 days; no trial measured muscle or fat
GH Secretagogues/GHRPs
- Bind the ghrelin receptor (GHS-R1a)
- Work through a different pathway than GHRH
- In a 2-year trial in older adults, oral MK-677 raised IGF-1 and fat-free mass but not strength; fasting glucose rose
Synergistic Effect
Infusion studies in men show GHRH plus a GHRP releases far more GH than either alone; a 2009 study found the synergy shrinks with age and abdominal fat. No controlled trial has tested the common Mod GRF 1-29 plus ipamorelin stack.
Pathway Diagram
- Hypothalamus: GHRH (+), somatostatin (-)
- Stomach: ghrelin (+) via the receptor GHRPs use
- Pituitary: GH released in pulses
- Liver: IGF-1 made
- Feedback: GH and IGF-1 damp release
Downstream Effects of GH
Direct GH Effects
- Lipolysis: breaks down fat for energy
- Protein synthesis: supports muscle maintenance
- Glucose regulation: opposes insulin
- Bone health: supports bone remodeling
IGF-1 Mediated Effects
- Muscle growth: carries much of GH's anabolic signal, though trials above saw no strength change
- Cell proliferation: tissue growth and repair
- Satellite cell activation: shown mainly in animals
Feedback Mechanisms
Negative Feedback
- GH and IGF-1 inhibit further GH release
- Acts on hypothalamus and pituitary
Peptide Advantages
- Work within natural feedback systems
- Preserve pulses: in a 2006 study, CJC-1295 raised trough GH 7.5-fold while pulse frequency and size were unchanged, contradicting the forum idea of a GH "bleed"
Timing and GH Pulses
Natural GH Pattern
- Largest pulses come in deep sleep; both decline by midlife in men
- Smaller pulses throughout day
- Exercise triggers release
- Fasting enhances secretion
Optimizing with Peptides
Users commonly describe three timings; none has been tested with peptides:
- Morning fasted: low glucose, on the theory of a bigger response
- Post-workout: adding to exercise GH
- Pre-bed: matching the sleep pulse (sermorelin trials dosed nightly)
Individual Variation
Factors Affecting Response
- Age (GH declines with age)
- Body composition
- Sleep quality
- Stress levels
- Baseline hormone status
Why Response Varies
- Receptor density differs
- Somatostatin tone varies
- Pituitary capacity differs
- IGF-1 production varies
Implications for Bodybuilders
Maximizing GH Response
- Many users avoid carbohydrate before injecting; untested
- Combining GHRH and GHRP is common practice
Understanding Limits
- Can't exceed pituitary capacity
- Natural feedback still operates
- As of October 2026, WADA prohibits GHRH analogs and GH secretagogues at all times (S2.2.4)
What we still don't know
Users report fading effects over months; see peptide cycling and desensitization. Long-term safety of raised IGF-1 is open (what happens after year one), and no trial shows these peptides build muscle in healthy lifters.
Stay Updated on Peptide Research
Get weekly breakdowns of new studies, dosing insights, and community protocols. No spam, unsubscribe anytime.
References
- Ghrelin is a growth-hormone-releasing acylated peptide from stomach (Nature, 1999)
- Fasting enhances growth hormone secretion and amplifies its rhythms in man (Journal of Clinical Investigation, 1988)
- Age-related changes in slow wave sleep and relationship with growth hormone in healthy men (JAMA, 2000)
- GH-releasing hormone, GH-releasing peptide and somatostatin under GH and IGF-1 feedback (Endocrine, 2003)
- Determinants of GHRH and GHRP synergy in men (American Journal of Physiology, 2009)
- CJC-1295 single- and multiple-dose trials in healthy adults (Journal of Clinical Endocrinology & Metabolism, 2006)
- Pulsatile GH secretion persists during CJC-1295 stimulation (Journal of Clinical Endocrinology & Metabolism, 2006)
- Nightly GHRH(1-29) injections in healthy elderly men (Metabolism, 1997)
- Two-year MK-677 trial in healthy older adults (Annals of Internal Medicine, 2008)
- FDA determination that Geref (sermorelin) was not withdrawn for safety or effectiveness (Federal Register, 2013)